Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Lifts 2026 Revenue Outlook to $3.10B-$3.20B

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$20.6
Mkt Cap
$6.099B
52W Low
$7.665
52W High
$19.26
52W Position info
169% above low
Off High info
at 52W high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $7.665.

Summary

Amneal raised its full-year 2026 revenue guidance to $3.10B-$3.20B, up from $3.05B-$3.15B, and also increased its adjusted EPS outlook to $0.96-$1.06 from $0.95-$1.05. The stock is already trading near a 52-week high, reflecting recent positive catalysts including FDA approvals and a pending Kashiv BioSciences acquisition. This upward revision adds to the momentum, suggesting the pipeline and commercial execution are delivering ahead of plan. The Kashiv deal, set for a shareholder vote, could further reshape the growth trajectory.

Updates

  1. · SEC 8-K — Q2 net revenue was $796 million, up 10% year over year; adjusted EBITDA was $206 million and adjusted diluted EPS was $0.30. Amneal repriced its $2.084B Term Loan B to SOFR plus 250 basis points, expected to save about $12 million in annual cash interest.

At the time of this announcement, AMRX was trading at $20.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $7.67 to $19.26. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 17, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.12
Real-time Price: $21.78 info
Change: +$0.6646 (+3%) info
Market Cap: $7.358B info
AMRX
Nov 09, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.28
Real-time Price: $21.78 info
Change: +$0.5046 (+2%) info
Market Cap: $7.358B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $21.78 info
Change: +$1.56 (+8%) info
Market Cap: $7.358B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $21.78 info
Change: +$1.58 (+8%) info
Market Cap: $7.358B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $21.78 info
Change: +$1.40 (+7%) info
Market Cap: $7.358B info